Caryn G. McDowell's Insider Trades & SAST Disclosures

Caryn G. McDowell's most recent trade in Quince Therapeutics Inc was a trade of 10,800 Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on June 6, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Quince Therapeutics Inc
Caryn G. McDowell Chief Legal & Adm. Officer Sale of securities on an exchange or to another person at price $ 2.86 per share. 06 Jun 2022 10,800 122,500 (0%) 0% 2.9 30,923 Common Stock
Quince Therapeutics Inc
Caryn G. McDowell Chief Legal & Adm. Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.86 per share. 06 Jun 2022 6,700 133,300 (0%) 0% 2.9 19,183 Common Stock
Quince Therapeutics Inc
Caryn G. McDowell Chief Legal & Adm. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 140,000 140,000 (0%) 0% 0 Common Stock
Quince Therapeutics Inc
Caryn G. McDowell Chief Legal & Adm. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 125,000 125,000 - - Stock Option (right to buy)
Quince Therapeutics Inc
Caryn G. McDowell Chief Legal & Adm. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2020 100,000 100,000 - - Stock Option (Right to Buy)
Quince Therapeutics Inc
Caryn G. McDowell Chief Legal & Adm. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2020 75,000 75,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades